Compare
Stimcell Energetics Inc. vs Odyssey Health, Inc. vs Global Innovative Platforms Inc. vs RetinalGenix Technologies Inc.
| Latest fiscal year | Stimcell Energetics Inc. STME | Odyssey Health, Inc. ODYY | Global Innovative Platforms Inc. GIPL | RetinalGenix Technologies Inc. RTGN |
|---|---|---|---|---|
| Year ended | 2026-05-31 | 2025-07-31 | 2025-09-30 | 2025-12-31 |
| Revenue | n/a | n/a | $0 | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | -$895.4K | -$1.74M | -$718.3K | -$2.43M |
| EPS (Diluted) | n/a | -$0.02 | -$0.02 | -$0.13 |
| Operating cash flow | -$312.1K | -$347.4K | -$560.7K | -$558.4K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | n/a | n/a | n/a | n/a |
| Total assets | $81.5K | $49.7K | $199.3K | $21.0K |
| Total liabilities | $1.89M | n/a | $11.6K | $2.32M |
| Shareholders' equity | -$1.81M | -$6.95M | $187.7K | -$2.30M |
| Return on year-end equity | n/a | n/a | -382.7% | n/a |
| Shares outstanding | n/a | 96.71M | 44.48M | 18.75M |
Revenue, most recent five fiscal years
| Fiscal year | Stimcell Energetics Inc. | Odyssey Health, Inc. | Global Innovative Platforms Inc. | RetinalGenix Technologies Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2024-05-31 | $0 Ended 2020-07-31 | $0 Ended 2025-09-30 | n/a |
| 1 year earlier | $2.8K Ended 2023-05-31 | $0 Ended 2019-07-31 | $0 Ended 2024-09-30 | n/a |
| 2 years earlier | n/a | $0 Ended 2018-07-31 | $0 Ended 2023-09-30 | n/a |
| 3 years earlier | n/a | $0 Ended 2017-07-31 | $0 Ended 2022-09-30 | n/a |
| 4 years earlier | $95.8K Ended 2020-05-31 | $37.5K Ended 2016-07-31 | $0 Ended 2021-09-30 | n/a |